FTMT
Basic information
Region (hg38): 5:121851882-121852833
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FTMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 2 | 0 |
Variants in FTMT
This is a list of pathogenic ClinVar variants found in the FTMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-121851982-C-T | not specified | Likely benign (Aug 05, 2024) | ||
5-121852024-C-T | not specified | Likely benign (Aug 01, 2024) | ||
5-121852025-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
5-121852030-C-T | not specified | Uncertain significance (May 30, 2024) | ||
5-121852064-C-A | not specified | Uncertain significance (Aug 20, 2024) | ||
5-121852067-G-C | not specified | Uncertain significance (Aug 20, 2024) | ||
5-121852105-C-T | not specified | Uncertain significance (Mar 21, 2022) | ||
5-121852130-G-C | not specified | Uncertain significance (Dec 11, 2024) | ||
5-121852139-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
5-121852182-C-A | not specified | Uncertain significance (Oct 06, 2021) | ||
5-121852309-C-A | not specified | Uncertain significance (Sep 29, 2022) | ||
5-121852360-C-A | not specified | Uncertain significance (Jan 06, 2023) | ||
5-121852370-G-C | not specified | Uncertain significance (Sep 08, 2024) | ||
5-121852417-G-T | not specified | Uncertain significance (Nov 29, 2024) | ||
5-121852442-T-C | not specified | Uncertain significance (Mar 16, 2022) | ||
5-121852471-G-A | not specified | Uncertain significance (Dec 06, 2021) | ||
5-121852475-A-G | not specified | Uncertain significance (Feb 10, 2022) | ||
5-121852480-T-A | not specified | Uncertain significance (Sep 08, 2024) | ||
5-121852550-A-G | not specified | Uncertain significance (Jul 12, 2023) | ||
5-121852588-G-C | not specified | Uncertain significance (Sep 03, 2024) | ||
5-121852593-C-A | not specified | Uncertain significance (Sep 04, 2024) | ||
5-121852613-A-T | not specified | Uncertain significance (Nov 08, 2022) | ||
5-121852628-A-T | not specified | Uncertain significance (Feb 05, 2025) | ||
5-121852640-C-G | not specified | Uncertain significance (Feb 14, 2023) | ||
5-121852653-T-G | not specified | Uncertain significance (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FTMT | protein_coding | protein_coding | ENST00000321339 | 1 | 870 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00561 | 0.736 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0415 | 163 | 162 | 1.01 | 0.0000113 | 1555 |
Missense in Polyphen | 33 | 36.548 | 0.90292 | 393 | ||
Synonymous | -0.454 | 83 | 77.9 | 1.07 | 0.00000609 | 509 |
Loss of Function | 0.803 | 4 | 6.15 | 0.651 | 3.46e-7 | 66 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. {ECO:0000269|PubMed:11323407, ECO:0000269|PubMed:15201052}.;
- Pathway
- Ferroptosis - Homo sapiens (human);Hereditary Coproporphyria (HCP);Porphyria Variegata (PV);Congenital Erythropoietic Porphyria (CEP) or Gunther Disease;Acute Intermittent Porphyria;Porphyrin Metabolism;Transport of small molecules;Methionine and cysteine metabolism;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.347
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.12
Haploinsufficiency Scores
- pHI
- 0.0630
- hipred
- N
- hipred_score
- 0.170
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0502
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ftmt
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- iron ion transport;cellular iron ion homeostasis;intracellular sequestering of iron ion;positive regulation of cell population proliferation;positive regulation of lyase activity;oxidation-reduction process;positive regulation of succinate dehydrogenase activity;positive regulation of aconitate hydratase activity
- Cellular component
- nucleus;cytoplasm;mitochondrial matrix
- Molecular function
- ferroxidase activity;iron ion binding;ferrous iron binding;ferric iron binding;identical protein binding